Blood tagging is the practice of labeling a component of blood, whether red cells, white cells, platelets, or even the water in arterial plasma, with a tracer that makes it visible on medical imaging. The technique lets clinicians track where blood flows, where it pools, and where it leaks without opening the body. Depending on which blood component gets labeled and which tracer is used, blood tagging can pinpoint a slow bleed in the gut, measure how well the heart pumps, map blood flow through the brain, or confirm whether a liver mass is benign. The approaches vary widely, from radioactive isotopes attached to cells in a laboratory to magnetic pulses applied inside an MRI scanner, but they all share the same logic: turn the blood itself into a contrast agent and watch where it goes.
How Red Blood Cells Get Tagged
The most common form of blood tagging in nuclear medicine involves attaching the radioactive isotope technetium-99m to red blood cells. Technetium-99m is favored because it emits gamma rays at an energy level well suited to gamma cameras, it has a short half-life of about six hours (long enough to image, short enough to limit radiation dose), and it binds stably to the hemoglobin inside red cells. An earlier isotope, chromium-51, was used for decades but had serious limitations: it leaked unpredictably from cells during the first day, delivered a higher radiation dose, and produced images too poor to be clinically useful for fast-moving problems.
The switch to technetium-99m solved these problems. A 1984 study demonstrated that technetium-99m labeling created an extremely stable bond with red blood cells, combining good dosimetry with imaging quality that chromium-51 could not match, particularly for investigating rapid processes like hemolysis after a mismatched transfusion.1PubMed. Tc-99m red blood cells for the study of rapid hemolytic processes associated with heterologous blood transfusions That advance opened the door to the clinical applications now considered routine.
There are two main ways to perform the labeling. In the in vivo method, a reducing agent is injected into the patient first, followed by technetium-99m; the isotope binds to red cells while they circulate. In the in vitro method, a sample of the patient’s blood is drawn, the labeling chemistry happens in a shielded vial, and the tagged cells are reinjected. The in vitro approach achieves a higher binding efficiency, meaning fewer free technetium molecules floating around to create confusing background signal on the scan.2PubMed. Effects of in vitro versus in vivo red cell labeling on image quality in gastrointestinal bleeding studies In practice, the choice often comes down to speed versus image clarity: in vivo labeling is faster to set up, while in vitro labeling generally produces cleaner images.
Finding a Gastrointestinal Bleed
One of the highest-impact uses of tagged red blood cells is locating the source of gastrointestinal bleeding, especially when the bleeding is intermittent or too slow for other tests to catch. Once the labeled red cells are circulating, a gamma camera captures images of the abdomen over time. If blood is leaking into the bowel, the radioactive tracer accumulates at the bleeding site and shows up as a hot spot that moves through the intestine on sequential images.
Tagged red blood cell scintigraphy can theoretically detect bleeding rates as low as 0.1 to 0.4 mL per minute, making it considerably more sensitive than conventional angiography, which typically requires a bleeding rate of 1.0 to 1.5 mL per minute to identify the hemorrhage site.3PubMed Central. Detection of ileal bleeding with tagged 99mTc red blood cell scan That sensitivity matters because many gastrointestinal bleeds are intermittent. A patient may be actively losing blood but not bleeding fast enough at the exact moment an angiogram is performed. Tagged red cells stay in the bloodstream for hours, so imaging can continue and catch a bleed that starts and stops.
The scan is not perfect, though. A number of things can mimic a bleeding site and produce a false positive. Slow-filling varices, for instance, can look like a fresh hemorrhage on the images.4PubMed Central. False positive GI bleed on Tc-99m RBC scintigraphy due to ileal varices And the list of potential confounders is long: activity from a normal kidney or transplanted kidney, urine in the bladder, a dilated aorta, bowel ischemia, hepatic hemangiomas, vascular collaterals, inflammatory bowel disease, or even normal postoperative blood flow after abdominal surgery can all complicate interpretation.5Journal of Nuclear Medicine. Gastrointestinal Bleeding Scintigraphy in the Early 21st Century Experienced nuclear medicine physicians learn to recognize these pitfalls, but a scan result always needs to be interpreted alongside the patient’s clinical picture, not treated as a standalone answer.
Monitoring the Heart
Tagged red blood cells also play a central role in evaluating cardiac function through a technique called a MUGA scan (multigated acquisition scan, sometimes called radionuclide ventriculography). After injection of technetium-99m-labeled red cells, the gamma camera is synchronized to the patient’s heartbeat using an ECG signal. By gating image acquisition to the cardiac cycle, the camera builds a moving picture of the heart’s chambers filling and emptying. The result is a precise measurement of the ejection fraction, the percentage of blood pumped out of the left ventricle with each beat.
MUGA scans have lower variability between different readers compared to standard two-dimensional echocardiography, which makes them especially valuable when you need consistent serial measurements over time.6Heliyon. Advanced imaging techniques in cardio-oncology: State of the art That consistency is why they remain a cornerstone of cardio-oncology. Certain chemotherapy drugs, particularly anthracyclines and trastuzumab, carry a risk of heart damage, and patients on these regimens need their heart function checked repeatedly. A MUGA scan can detect a drop in ejection fraction before the patient feels any symptoms.
Research has shown that MUGA can pick up diastolic dysfunction, a stiffening of the heart muscle that impairs filling, before systolic dysfunction (the pumping weakness measured by ejection fraction) becomes apparent. In one study of cancer patients receiving trastuzumab-based therapy, diastolic dysfunction preceded systolic dysfunction by an average of 73 days in patients who had normal diastolic function at baseline.7PubMed Central. Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy That kind of early warning gives cardiologists a window to intervene, adjusting medications or managing cardiovascular risk factors before the heart sustains lasting damage.
Diagnosing Liver Masses
When a mass is found in the liver on a CT or ultrasound, one of the key questions is whether it is a hemangioma, a common benign tangle of blood vessels, or something more worrisome like a metastasis. Tagged red blood cell scintigraphy helps answer that question because hemangiomas, being pools of blood, accumulate labeled red cells in a characteristic pattern: they show little or no activity on early images but gradually light up on delayed scans as tagged cells fill the slow-flowing blood spaces.
Adding single-photon emission CT (SPECT) to the planar images significantly improves performance. A landmark study found that six hemangiomas smaller than 2.5 centimeters were diagnosed by SPECT that would have been missed by planar imaging alone, and the combined approach was at least as reliable as dynamic CT for noninvasive diagnosis of hepatic cavernous hemangioma.8PubMed. Hepatic cavernous hemangioma: diagnosis with 99mTc-labeled red cells and single-photon emission CT Still, the test has limits. Some metastases and other benign lesions can take up labeled red cells enough to create ambiguity. A retrospective analysis of liver masses found to be positive on SPECT/CT with labeled blood cells showed that at least some lesions classified as metastases or non-hemangioma benign masses produced uptake ratios close to what hemangiomas typically show.9PubMed Central. To what extent can diverse types of liver lesions mimic hemangiomas? As with GI bleed scans, clinical context and complementary imaging guide the final diagnosis.
Tagging White Blood Cells and Platelets
Red cells are not the only blood component worth labeling. White blood cells can be extracted from a patient’s blood, tagged with technetium-99m (using the agent HMPAO) or indium-111, and reinjected. The idea is that these cells naturally migrate toward sites of infection and inflammation, so the tracer follows them there. Labeled white blood cell scans have been used for decades to locate abscesses, infected prosthetic joints, and osteomyelitis. European guidelines standardize the labeling protocol for technetium-99m-HMPAO-labeled leukocytes, including quality control steps to ensure the cells remain viable and functional after labeling.10PubMed Central. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
The technique works well for certain clinical questions but struggles in others. A study of 132 patients with fever of unknown origin found that labeled white blood cell scans had limited clinical value in that population. Only about 14% of all scans produced findings that could be confirmed as true positives, and of those, the vast majority were not clinically helpful. In total, only two scans out of 132 contributed to the final diagnosis, and they did so only indirectly. Meanwhile, false-positive results led to seven unnecessary procedures.11Oxford Academic (Open Forum Infectious Diseases). Lack of Clinical Utility of Labeled White Blood Cell Scintigraphy in Patients With Fever of Unknown Origin The takeaway is not that white cell tagging is useless, but that it works best when there is already a focused clinical suspicion, such as a suspected infected joint or an abscess suggested by other imaging, rather than as a broad screening tool.
Platelets can be tagged too, though this is less common. Radioactively labeled platelets have been used to study platelet survival, assess splenic uptake, and diagnose conditions like idiopathic thrombocytopenia and deep vein thrombosis.12Aston University. Development of labelled platelets as radiopharmaceuticals The labeling process for platelets is more delicate than for red cells because platelets are easily activated, which would change their behavior once reinjected. This technical challenge has kept platelet tagging largely in the realm of specialized research centers rather than everyday clinical practice.
Magnetic Blood Tagging Without Radioactivity
Not all blood tagging involves radioactive isotopes. In MRI, a family of techniques collectively known as arterial spin labeling (ASL) uses the magnetic properties of water molecules in arterial blood as a built-in tracer. The scanner applies a brief radiofrequency pulse that flips the magnetic spin of hydrogen nuclei in blood flowing toward the tissue of interest. When that magnetically “tagged” blood arrives in the tissue, it alters the local MRI signal just enough to be detected. By comparing images acquired with and without the tagging pulse, software calculates a map of blood flow.
The foundational work in this area showed that continuously inverting arterial water proton spins at the neck and observing the effect on brain MRI signal could produce perfusion images without any injected contrast agent.13PubMed. Magnetic resonance imaging of perfusion using spin inversion of arterial water Follow-up work demonstrated that this approach could quantify human brain perfusion at clinically available field strengths, effectively using magnetically inverted arterial water as a freely diffusible blood flow tracer.14PubMed. Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water The beauty of the technique is that the “label” is just the patient’s own blood with its hydrogen spins flipped. No injection, no radiation, and the measurement can be repeated as many times as needed in a single session.
ASL has found an expanding list of clinical uses in neuroimaging. A consensus position paper provides guidance on applying ASL in acute ischemic stroke, arteriovenous malformations, brain tumors, neurodegenerative disease, epilepsy, and pediatric neuroradiology.15PubMed Central. Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging In Alzheimer’s disease and frontotemporal dementia, ASL reveals characteristic patterns of reduced blood flow that mirror the metabolic patterns seen on PET scans, offering a radiation-free alternative for diagnosis and monitoring.16PubMed Central. A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice
A more advanced version, vessel-encoded ASL, can distinguish blood arriving through different arteries. In stroke patients, this matters because the brain often receives rescue blood flow through alternative routes called collateral vessels. A study using vessel-encoded ASL found that tissue receiving collateral blood flow above a certain threshold had a significantly higher survival rate: about 75% of at-risk brain tissue survived when collateral perfusion was adequate, compared with roughly 60% when it was not.17Scientific Reports. Measurement of collateral perfusion in acute stroke: a vessel-encoded arterial spin labeling study That kind of information could help clinicians decide how aggressively to pursue clot-removal procedures.
Tagging the Heart Muscle Itself
A separate MRI technique, often called myocardial tagging, applies a grid-like pattern of magnetic saturation lines directly onto the heart muscle before it contracts. As the heart beats, those tag lines deform, and analyzing how they warp reveals exactly how the muscle fibers are shortening, thickening, and twisting. Two major approaches exist: spatial modulation of magnetization (SPAMM) and displacement encoding with stimulated echoes (DENSE), both of which quantify myocardial displacement and strain.18PubMed. Generalized spatiotemporal myocardial strain analysis for DENSE and SPAMM imaging
SPAMM tagging was validated against sonomicrometry, a surgical technique that places tiny crystals directly into the heart wall to measure deformation with high precision.19PubMed. Validation of in vivo myocardial strain measurement by magnetic resonance tagging with sonomicrometry The close agreement between the two methods established MRI tagging as a trustworthy noninvasive measure of heart mechanics. Clinically, this matters for conditions where the heart’s pumping efficiency looks normal on standard tests but the muscle itself is contracting abnormally, such as in early cardiomyopathy or after a heart attack when some regions of the wall move less than others.
Blood Tagging in Anti-Doping
Blood tagging takes on a very different meaning in the world of sports. Autologous blood transfusion, where an athlete stores their own blood and reinfuses it before competition to boost oxygen-carrying capacity, has been banned since the 1980s but remains notoriously difficult to detect. Unlike transfusions of someone else’s blood, autologous blood does not introduce foreign proteins or mismatched cell markers, so standard blood-typing tests cannot catch it.
Researchers have pursued several strategies that essentially try to “read the tags” that storage leaves on red blood cells. When blood is refrigerated in a storage bag, the red cells age in predictable ways. Membrane proteins like Band 3 and glycophorin A decrease substantially during storage (one study documented decreases of roughly 19% and 47% respectively after 20 days, with further drops by 40 days), while markers of cell damage like externalized phosphatidylserine increase dramatically.20PubMed Central. Age-Markers on the Red Blood Cell Surface and Erythrocyte Microparticles may Constitute a Multi-parametric Strategy for Detection of Autologous Blood Transfusion If a blood sample from an athlete contains a mix of fresh cells and cells bearing these storage-related changes, it suggests reinfusion.
Other detection approaches look beyond the cells themselves. Stored blood is kept in plastic bags that leach a plasticizer called DEHP, and the presence of DEHP metabolites in an athlete’s urine can suggest a recent transfusion. Shifts in iron metabolism markers like hepcidin are another avenue, since donating blood and later reinfusing it creates distinctive swings in the body’s iron regulation. Proteomic and transcriptomic methods, analyzing changes in RNA and protein profiles, are also under development as part of what researchers call an “ironomics” strategy for indirect detection.21Transfusion Medicine Reviews. Autologous Blood Transfusion in Sports: Emerging Biomarkers None of these methods has yet been adopted as a standalone anti-doping test, but the multi-marker approach, combining several of these signals, is moving closer to practical implementation.
Nanoparticles and PET-Based Approaches
Researchers continue to look for better tracers. One line of work has developed fluorescent nanoparticles designed to circulate in the bloodstream and act as tiny beacons visible under intravital microscopy. These particles were engineered for neutral charge and extreme brightness, producing fluorescence more than a thousand times greater than conventional dye-labeled red blood cells, and could be tracked at speeds up to 4,000 micrometers per second.22PubMed. Multi-image particle tracking velocimetry of the microcirculation using fluorescent nanoparticles Smaller particles stayed in circulation longer, though regardless of size, the liver captured more than half of the recovered fluorescence, a reminder that the body’s filtering systems are always working to clear foreign objects from the blood.23PubMed. Biological and optical properties of fluorescent nanoparticles developed for intravascular imaging For now, fluorescent nanoparticle tracking remains a research tool rather than a clinical one, used primarily to study blood flow at the microscopic level in animal models.
On the clinical side, there is growing interest in labeling red blood cells with fluorine-18, the PET isotope used in standard cancer scans, instead of technetium-99m. PET offers higher spatial resolution than traditional gamma-camera imaging. A preclinical study in rats showed that red blood cells labeled with fluorine-18-FDG persisted strongly in the cardiovascular system for at least two hours and could clearly visualize both temporary and persistent intra-abdominal bleeding on dynamic PET imaging.24PubMed Central. 18 F-FDG-labeled red blood cell PET for blood-pool imaging: preclinical evaluation in rats If this approach translates to humans, it could combine the proven logic of tagged red blood cell scans with the sharper images and quantitative capabilities of modern PET/CT scanners, potentially improving detection of subtle or intermittent bleeding and enabling more accurate measurements of cardiac blood-pool volumes.
Why So Many Variations Exist
It might seem odd that a single concept, making blood visible on a scanner, has spawned so many techniques. The reason is that different clinical questions demand different properties from the tracer. A GI bleed scan needs red cells that stay labeled for hours so you can catch intermittent hemorrhage. A brain perfusion map needs a tracer that arrives and washes out quickly so you can measure flow rates rather than pooling. A white cell scan needs cells that home in on inflammation. A heart wall motion study needs tags that deform with the muscle. No single tracer or labeling strategy does all of these things well, so the field has evolved a toolkit where each approach is optimized for a specific diagnostic question.
The patient’s condition also matters. ASL perfusion imaging requires no injection and no radiation, making it ideal for children, pregnant women, or patients who need repeated scans. MUGA scans involve a small radiation dose but provide the reproducibility that oncologists rely on for serial monitoring. Tagged white cell scans involve both radiation and the handling of the patient’s blood outside the body, making them a heavier intervention reserved for situations where simpler tests have failed. Clinicians choose the technique that balances diagnostic accuracy, patient burden, and the specific clinical question being asked.